AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
AKCA
Delisted
AKCA was delisted on the 9th of October, 2020.
62 hedge funds and large institutions have $338M invested in Akcea Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
-6
Holders Change %
-8.82%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
16
Reduced
24
Closed
14
Calls
$4.38M
Puts
$5.84M
Net Calls
-$1.46M
Net Calls Change
+$44K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$26.2M |
| 2 |
2
Russell Investments Group
London,
United Kingdom
|
$949K |
| 3 |
3
D.E. Shaw & Co
New York
|
$874K |
| 4 |
ARTA
4
A.R.T. Advisors
New York
|
$445K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$419K |
